Unbound MEDLINE

Synthesis, biological activity, and SAR of antimycobacterial 9-aryl-, 9-arylsulfonyl-, and 9-benzyl-6-(2-furyl)purines. Journal of medicinal chemistry. [J Med Chem] Journal article

 
TitleSynthesis, biological activity, and SAR of antimycobacterial 9-aryl-, 9-arylsulfonyl-, and 9-benzyl-6-(2-furyl)purines.
Author(s)Bakkestuen AK, Gundersen LL, Utenova BT 
InstitutionDepartment of Chemistry, University of Oslo, P.O. Box 1033, Blindern, N-0315 Oslo, Norway.
SourceJ Med Chem 2005 Apr 7; 48(7):2710-23.
MeSHAnimals
Antitubercular Agents
Cercopithecus aethiops
Furans
In Vitro
Macrophages
Mice
Microbial Sensitivity Tests
Mycobacterium avium Complex
Mycobacterium tuberculosis
Purines
Research Support, Non-U.S. Gov't
Structure-Activity Relationship
Sulfones
Vero Cells
Abstract9-Aryl-, 9-arylsulfonyl- and 9-benzyl-6-(2-furyl)purines were synthesized by N-alkylation or N-arylation of the purine followed by Stille coupling to introduce the furyl substituent in the 6-position and the compounds screened for activity against Mycobacterium tuberculosis. The 9-aryl- and 9-sulfonylarylpurines exhibited weak activity toward the bacteria, but 9-benzylpurines were good inhibitors especially those carrying electron-donating substituents on the phenyl ring. A chlorine atom in the purine 2-position further enhanced activity. The high antimycobacterial activity (MIC 0.39 microg/mL against M. tuberculosis), low toxicity against mammalian cells and activity inside macrophages found for 2-chloro-6-(2-furyl)-9-(4-methoxyphenylmethyl)-9H-purine makes this compound a highly interesting potential antituberculosis drug.
Languageeng
Pub Type(s)Journal Article
PubMed ID15801862
  
Advertise on this site.